Shire Pharmaceuticals – pharmaceutical daily

May 29, 2020 Off

European Commission Releases Takeda From Commitment to Divest Shire’s Pipeline Compound SHP647

OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) today announces that on May 28, the European Commission (the “EC”)…

November 30, 2018 Off

Shire nets European approval for Takhzyro, which can prevent potentially deadly hereditary angiodema

By Dino Mustafić

Shire got the good news from the European Commission (EC) for Marketing Authorisation for Takhzyro injection, for prevention of recurrent…

January 18, 2017 Off

Galapagos appoints Chief Medical Officer

By Dino Mustafić

Galapagos has appointed Dr. Walid Abi-Saab as a Chief Medical Officer (CMO), who came from Shire Pharmaceuticals, beginning on March 1, 2017.